Trilogy Writing & Consulting

Trilogy Writing & Consulting provides high-end medical writing services for clinical, regulatory, safety, and medical content. It specializes in supporting pharmaceutical, biotechnology, consumer health, and medical device companies with documentation required for regulatory submissions and communications. The company has over 22 years of experience and global reach across Germany, the UK, and the US[6][7].

In March 2024 it was acquired by Indegene Ireland Ltd., a subsidiary of Indegene Limited[6][7].

Key therapeutic areas supported include oncology, immunology, neurosciences, urology, anti-infectives, endocrinology, respiratory diseases among others[6][7].

The company does not have its own clinical pipeline or products.

It applies lean principles and novel operating models to produce submission-ready content efficiently. It also leverages AI-enabled technology to streamline document creation[6][7].

Clients include pharmaceutical companies of all sizes as well as contract research organizations worldwide[1][2][5].